NASDAQ:LHDX

Lucira Health Stock Forecast, Price & News

$18.27

-1.12 (-5.78 %)

(As of 03/2/2021 12:00 AM ET)

Add

Compare

Today's Range

$17.39

Now: $18.27▼

$19.20

50-Day Range N/A

52-Week Range

$17.39

Now: $18.27▼

$37.99

Volume306,693 shs

Average Volume478,045 shs

Market Capitalization$675.31 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It has developed a testing platform that produces COVID-19 single-use test kit with molecular accuracy. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was founded in 2013 and is headquartered in Emeryville, California.

Headlines

Do You Have These Top Health Care Stocks On Your Watchlist? 4 Making Waves
February 18, 2021 | nasdaq.com

Lucira Health's COVID-19 Molecular Testing Kits Dubbed The Gold Standard
February 14, 2021 | seekingalpha.com

U.S. Physicians Can Now Order Lucira Health Self-Administered, Lab Quality, COVID-19 Molecular Test for Home or Office
February 11, 2021 | finance.yahoo.com

Lucira Health Inc
February 9, 2021 | reuters.com

Lucira Health Announces Closing of its Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 9, 2021 | finance.yahoo.com

Lucira Health Announces Pricing of Its Upsized Initial Public Offering
February 8, 2021 | finance.yahoo.com

The Wave of Biotech IPOs Continues. Here Are 7 Stocks That Hit the Market
February 8, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Diagnostics & Research

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:LHDX

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.lucirahealth.com

Phone510 350 8071

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares36,963,000

Market Cap$675.31 million

Next Earnings DateN/A

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.83 out of 5 stars

Medical Sector

1124th out of 1,968 stocks

Diagnostics & Research Industry

4th out of 13 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Lucira Health.

2.5 Community Rank

Outperform Votes
Lucira Health has received 1 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Lucira Health has received 1 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Lucira Health has received 50.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Lucira Health and other stocks. Vote “Outperform” if you believe LHDX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LHDX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Lucira Health does not currently pay a dividend.
Dividend Growth
Lucira Health does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Lucira Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $58,849,988.00 in company stock and sold $0.00 in company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

$18.27

-1.12 (-5.78 %)

(As of 03/2/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive LHDX News and Ratings via Email

Sign-up to receive the latest news and ratings for LHDX and its competitors with MarketBeat's FREE daily newsletter.

Lucira Health (NASDAQ:LHDX) Frequently Asked Questions

What stocks does MarketBeat like better than Lucira Health?

Wall Street analysts have given Lucira Health a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Lucira Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Lucira Health's key executives?

Lucira Health's management team includes the following people:

Mr. Erik T. Engelson, Pres, CEO & Director (Age 61)
Mr. Daniel V. George, CFO & Treasurer (Age 51)
Ms. Tamanna Prashar, VP of Global Supply Chain, Operations & Quality (Age 39)
Dr. Debkishore Mitra Ph.D., CTO & Director (Age 34)
Ms. Kelly Lewis Brezoczky, Exec. VP of Commercialization, Regulatory, Clinical & Bus. Devel. (Age 57)

Who are some of Lucira Health's key competitors?

Some companies that are related to Lucira Health include MaxCyte (MXCT), Renalytix AI plc (RENX.L) (RENX), Profound Medical Corp. (PRN.TO) (PRN), Biodesix (BDSX), Akumin (AKU), Akumin (AKU), Oncimmune (ONC), Yourgene Health (YGEN), Relay Medical (RYMDF), LexaGene (LXG), genedrive (GDR), Global WholeHealth Partners (GWHP), SQI Diagnostics Inc. (SQD.V) (SQD), Sernova Corp. (SVA.V) (SVA) and GeneNews (GEN).
View all of LHDX's competitors.

When did Lucira Health IPO?

(LHDX) raised $125 million in an initial public offering (IPO) on Friday, February 5th 2021. The company issued 7,800,000 shares at a price of $15.00-$17.00 per share. BofA Securities, William Blair and LifeSci Capital served as the underwriters for the IPO.

What is Lucira Health's stock symbol?

Lucira Health trades on the NASDAQ under the ticker symbol "LHDX."

When does the company's quiet period expire?

Lucira Health's quiet period expires on Wednesday, March 17th. Lucira Health had issued 9,000,000 shares in its IPO on February 5th. The total size of the offering was $153,000,000 based on an initial share price of $17.00. During the company's quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Lucira Health?

Shares of LHDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lucira Health's stock price today?

One share of LHDX stock can currently be purchased for approximately $18.27.

How much money does Lucira Health make?

Lucira Health has a market capitalization of $675.31 million.

What is Lucira Health's official website?

The official website for Lucira Health is www.lucirahealth.com.

How can I contact Lucira Health?

The company can be reached via phone at 510 350 8071.

This page was last updated on 3/3/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here